Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dr Agarwal’s Health CareBOM:544350 -0.43%17 Shareholder Yield % is -0.16% as of Jun. 2026. GuruFocus rates BOM:544350 with a GF Score™ of 17/100. The stock has 4 warning signs investors should review. Among 818 Medical Devices & Instruments companies, Dr Agarwal’s Health Care ranks worse than 55.01% on this metric.
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. It is a measure of shareholder return.
As of today, Dr Agarwal’s Health Care's Shareholder Yield % was -0.16%.
Dr Agarwal’s Health Care (BOM:544350) Shareholder Yield % Explanation
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. The term was coined by William W. Priest of Epoch Investment Partners in a paper in 2005 entitled The Case for Shareholder Yield as a Dominant Driver of Future Equity Returns. William Priest indicated that "shareholder yield is a term that we came up with to reflect the various ways dividends can be paid to owners of a business in a publicly-traded company."
Dividend Yield % shows how much a company pays out in dividends each year relative to its stock price, which is most obvious form of shareholder return.
Buyback Yield % is the net repurchase of shares outstanding over the market capital of the company. Shares repurchases also increase shareholder value by returning the money back to shareholders.
Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced.
Dr Agarwal’s Health Care Shareholder Yield % Related Terms
Dr Agarwal’s Health Care Shareholder Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dr Agarwal’s Health Care Shareholder Yield % Chart
BOM:544350 vs ISRG, BDX, MDLN: Shareholder Yield % Comparison
For the Medical Instruments & Supplies subindustry, Dr Agarwal’s Health Care's Shareholder Yield %, along with its competitors' market caps and Shareholder Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr Agarwal’s Health Care Shareholder Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Dr Agarwal’s Health Care's Shareholder Yield % distribution charts can be found below:
* The bar in red indicates where Dr Agarwal’s Health Care's Shareholder Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Shareholder Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.
Dr Agarwal’s Health Care (BOM:544350) has a Shareholder Yield % of -0.16% as of Jun. 2026. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Dr Agarwal’s Health Care and its competitors. According to the industry distribution chart, Dr Agarwal’s Health Care ranks #450 out of 818 companies in the Medical Devices & Instruments industry, placing it in the top 55%.
Is Dr Agarwal’s Health Care's Shareholder Yield % too high?
Dr Agarwal’s Health Care's current Shareholder Yield % is -0.16%. Based on the distribution chart, Dr Agarwal’s Health Care ranks #450 out of 818 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Dr Agarwal’s Health Care has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Dr Agarwal’s Health Care's Shareholder Yield % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Dr Agarwal’s Health Care ranks #450 out of 818 companies for Shareholder Yield %. This places Dr Agarwal’s Health Care in the lower half of its industry. The industry median Shareholder Yield % is 0.20. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shareholder Yield % for a Medical Devices & Instruments company?
The median Shareholder Yield % among Medical Devices & Instruments companies is 0.20, based on 818 companies in the industry. Companies in the top quartile (top 25%) have a Shareholder Yield % significantly above this median, while those in the bottom quartile fall well below. However, Shareholder Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shareholder Yield % mean?
A high Shareholder Yield % can signal that a stock is expensive relative to its fundamentals. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Dr Agarwal’s Health Care and its competitors. For the Medical Devices & Instruments industry, the median Shareholder Yield % is 0.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dr Agarwal’s Health Care's current Shareholder Yield % is -0.16%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr Agarwal’s Health Care stock overvalued right now?
Dr Agarwal’s Health Care (BOM:544350) has a current Shareholder Yield % of -0.16%. The current Shareholder Yield % is -0.16%. Dr Agarwal’s Health Care's overall GF Score™ is 17/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shareholder Yield % calculated?
Shareholder Yield % is calculated from a company's financial statements. For Dr Agarwal’s Health Care (BOM:544350), the current Shareholder Yield % is -0.16% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Dr Agarwal's Health Care Ltd is engaged in eye care services, including cataract, refractive and other surgeries; consultations, diagnoses and non-surgical treatments; and sell opticals, contact lenses and accessories, and eye care related pharmaceutical products. It offer services such as Surgeries, Cataract surgeries, Refractive surgeries, Other surgeries, and Consultations, diagnoses and non-surgical treatments, Its products services include Sale of opticals and Sale of eye care-related pharmaceutical products. The company is engaged in single segment that is eye care and related services provided from its hospitals which are located in India and Africa. It generates maximum revenue from India.
17GF Score
Get the complete analysis for BOM:544350
Shareholder Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544350 has been successfully added to your 
